PDA APAC – Advanced Parenteral Therapeutics & Quality Summit 2026
Regulatory expectations are evolving rapidly—and for advanced parenteral therapies, quality systems must evolve with them.
Novatek International is pleased to announce that Neeraj Choudhary and Bobbi Bi will be attending the PDA Advanced Parenteral Therapeutics & Quality Summit 2026, taking place September 22–23, 2026, at the ILLUME Hotel Taipei in Taipei, Taiwan.
The summit brings together regulators, quality professionals, manufacturers, and technology innovators to address advanced therapeutics, sterile manufacturing, contamination control strategies, Annex 1 implementation, sterility assurance, and risk-based quality management.
For pharmaceutical QA, QC, validation, and manufacturing leaders, these discussions are critical to building resilient, inspection-ready operations while maintaining data integrity, compliance, and manufacturing efficiency.
Novatek supports pharmaceutical organizations with regulatory-compliant solutions spanning LIMS, QMS, environmental monitoring, cleaning validation, stability management, and other quality processes.
Register or learn more about the summit: PDA Advanced Parenteral Therapeutics & Quality Summit 2026
Explore Novatek International: https://ntint.com/ to discover software solutions designed to strengthen quality, compliance, and risk management across pharmaceutical operations.
What quality challenge will have the greatest impact on advanced parenteral manufacturing in the years ahead?
#PharmaceuticalManufacturing #QualityAssurance #ParenteralTherapeutics #ContaminationControl #PharmaCompliance